Reticular dysgenesis caused by an intronic pathogenic variant in AK2

Cold Spring Harb Mol Case Stud. 2020 Jun 12;6(3):a005017. doi: 10.1101/mcs.a005017. Print 2020 Jun.

Abstract

Reticular dysgenesis is a form of severe combined immunodeficiency (SCID) caused by biallelic pathogenic variants in AK2 Here we present the case of a boy diagnosed with SCID following a positive newborn screen (NBS). Genetic testing revealed a homozygous variant: AK2 c.330 + 5G > A. In silico analyses predicted weakened native donor splice site. However, this variant was initially classified as a variant of uncertain significance (VUS) given lack of direct evidence. To determine the impact on splicing, we analyzed RNA from the proband and his parents, using massively parallel RNA-seq of cloned RT-PCR products. Analysis showed that c.330 + 5G > A results in exon 3 skipping, which encodes a critical region of the AK2 protein. With these results, the variant was upgraded to pathogenic, and the patient was given a diagnosis of reticular dysgenesis. Interpretation of VUS at noncanonical splice site nucleotides presents a challenge. RNA sequencing provides an ideal platform to perform qualitative and quantitative assessment of intronic VUS, which can lead to reclassification if a significant impact on mRNA is observed. Genetic disorders of hematopoiesis and immunity represent fruitful areas to apply RNA-based analysis for variant interpretation given the high expression of RNA in blood.

Keywords: severe combined immunodeficiency.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adenylate Kinase / genetics*
  • Alleles
  • DNA Mutational Analysis
  • Exons
  • Genetic Association Studies*
  • Genetic Predisposition to Disease*
  • Genetic Variation*
  • Humans
  • Infant
  • Infant, Newborn
  • Introns*
  • Leukopenia / diagnosis*
  • Leukopenia / genetics*
  • Leukopenia / therapy
  • Male
  • Mutation
  • Peripheral Blood Stem Cell Transplantation
  • Phenotype
  • RNA Splicing
  • Severe Combined Immunodeficiency / diagnosis*
  • Severe Combined Immunodeficiency / genetics*
  • Severe Combined Immunodeficiency / therapy
  • Treatment Outcome

Substances

  • Adenylate Kinase
  • adenylate kinase 2

Supplementary concepts

  • Reticular dysgenesis